Trial intelligence / Profile preview

OC-01 (varenicline) in Contact Lens Wearers with Dry Eye

NCT05161208Phase 4Completed

Sponsor
Center for Ophthalmic and Vision Research
Start
Dec 2021
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of varenicline + nicotine patch in dry eye disease (DED), sponsored by Center for Ophthalmic and Vision Research. Started Dec 2021; status: completed.

02

Drugs

varenicline + nicotine patch
03

Conditions

dry eye disease (DED)

Beyond the preview

Go deeper on NCT05161208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05161208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call